Shailaja Jamma

Summary

Publications

  1. pmc Celiac crisis is a rare but serious complication of celiac disease in adults
    Shailaja Jamma
    Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Gastroenterol Hepatol 8:587-90. 2010
  2. doi request reprint Small intestinal release mesalamine for the treatment of refractory celiac disease type I
    Shailaja Jamma
    Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Clin Gastroenterol 45:30-3. 2011
  3. doi request reprint The incidence and clinical spectrum of refractory celiac disease in a north american referral center
    Bakht Roshan
    Department of Gastroenterology, Celiac Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Am J Gastroenterol 106:923-8. 2011
  4. doi request reprint A validated disease-specific symptom index for adults with celiac disease
    Daniel A Leffler
    Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Gastroenterol Hepatol 7:1328-34, 1334.e1-3. 2009
  5. doi request reprint A simple validated gluten-free diet adherence survey for adults with celiac disease
    Daniel A Leffler
    Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Gastroenterol Hepatol 7:530-6, 536.e1-2. 2009

Detail Information

Publications5

  1. pmc Celiac crisis is a rare but serious complication of celiac disease in adults
    Shailaja Jamma
    Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Gastroenterol Hepatol 8:587-90. 2010
    ..To improve awareness of this condition and to facilitate diagnosis, we reviewed cases of celiac crisis to identify presenting features, formulate diagnostic criteria, and develop treatment strategies...
  2. doi request reprint Small intestinal release mesalamine for the treatment of refractory celiac disease type I
    Shailaja Jamma
    Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Clin Gastroenterol 45:30-3. 2011
    ..The goal of this study is to evaluate the safety and efficacy of Small intestinal release mesalamine (SIRM) for symptom relief in refractory celiac disease (RCD)...
  3. doi request reprint The incidence and clinical spectrum of refractory celiac disease in a north american referral center
    Bakht Roshan
    Department of Gastroenterology, Celiac Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Am J Gastroenterol 106:923-8. 2011
    ..However, disease patterns may be different in North America. The aim of this study was to explore the clinical spectrum of RCD in a North American population...
  4. doi request reprint A validated disease-specific symptom index for adults with celiac disease
    Daniel A Leffler
    Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Gastroenterol Hepatol 7:1328-34, 1334.e1-3. 2009
    ..Although the incidence of celiac disease (CD) is increasing, studies have been hampered by the lack of validated outcome measures. We sought to create a disease-specific Celiac Symptom Index (CSI) to reliably assess relevant symptoms...
  5. doi request reprint A simple validated gluten-free diet adherence survey for adults with celiac disease
    Daniel A Leffler
    Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Gastroenterol Hepatol 7:530-6, 536.e1-2. 2009
    ..The aim of this study was to develop a valid and reliable Celiac Dietary Adherence Test (CDAT)...